Where do Pediatrix Medical Group's ratios come from?

Every ratio is computed from Pediatrix Medical Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	10.9%—	——	——	8.8%-1.9pp
Net margin	8.6%—	——	-3%-6.4pp	3.4%-3.5pp
EBITDA margin	12.1%—	——	1.3%-9.2pp	10.6%-1.7pp
Free cash flow margin	13.2%+4.0pp	9.2%+4.0pp	5.2%-1.7pp	7%+4.6pp
Returns
Return on equity	20.3%—	——	-6.9%-14.4pp	7.4%-8.5pp
Return on assets	7.5%—	——	-2.6%-5.3pp	2.6%-1.7pp
Return on invested capital	13.7%—	——	-0.6%-12.8pp	12.1%—
Efficiency
Asset turnover	0.9×-0.1×	0.9×0.0×	0.9×+0.1×	0.8×+0.1×
Liquidity
Current ratio	1.7×+0.2×	1.5×+0.2×	1.2×+0.2×	1×-1.0×
Quick ratio	1.7×+0.2×	1.5×+0.2×	1.2×+0.2×	1×-1.0×
Cash ratio	0.8×+0.3×	0.5×+0.3×	0.2×+0.2×	0×-0.9×
Leverage
Debt-to-equity	0.7×-0.1×	0.9×0.0×	0.8×0.0×	0.8×+0.7×
Debt-to-assets	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×+0.3×
Net debt / EBITDA	1.1×—	——	24.3×+20.9×	3.4×+4.7×
Interest coverage	5.8×—	——	-0.2×-4.6×	4.4×+1.4×
Per Share
Book value per share	$10.14+10.4%	$9.18-11.1%	$10.33-2.6%	$10.60+1.5%
Valuation
Market capitalization	$1.84B+63.0%	$1.13B+44.2%	$781.37M-36.6%	$1.23B-46.5%
Enterprise value	$2.1B+34.2%	$1.56B+10.3%	$1.42B-27.1%	$1.95B-2.5%
Price / earnings	11.1×—	——	——	18.6×+1.0×
Price / sales	1×+0.4×	0.6×+0.2×	0.4×-0.2×	0.6×-0.6×
Price / book	2.1×+0.6×	1.5×+0.6×	0.9×-0.5×	1.4×-1.2×
EV / EBITDA	9.1×—	——	54.1×+44.8×	9.3×+0.9×
EV / sales	1.1×+0.3×	0.8×+0.1×	0.7×-0.3×	1×-0.1×
Free cash flow yield	13.8%-2.6pp	16.4%+3.1pp	13.3%+2.2pp	11.1%+9.2pp
Earnings yield	9%—	——	-7.7%-13.1pp	5.4%-0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Pediatrix Medical Group's ratios come from?: Every ratio is computed from Pediatrix Medical Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.